Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension.

Chen H, De Marco T, Kobashigawa EA, Katz PP, Chang VW, Blanc PD.

Eur Respir J. 2011 Sep;38(3):608-16. doi: 10.1183/09031936.00161410. Epub 2011 Jan 27.

PMID:
21273391
2.

Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension.

Zlupko M, Harhay MO, Gallop R, Shin J, Archer-Chicko C, Patel R, Palevsky HI, Taichman DB.

Respir Med. 2008 Oct;102(10):1431-8. doi: 10.1016/j.rmed.2008.04.016. Epub 2008 Jul 9.

PMID:
18617379
3.

Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.

Mathai SC, Suber T, Khair RM, Kolb TM, Damico RL, Hassoun PM.

Ann Am Thorac Soc. 2016 Jan;13(1):31-9. doi: 10.1513/AnnalsATS.201412-572OC.

PMID:
26492065
4.

Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study.

Gerhardt F, Dumitrescu D, Gärtner C, Beccard R, Viethen T, Kramer T, Baldus S, Hellmich M, Schönau E, Rosenkranz S.

Heart. 2017 Apr;103(8):592-598. doi: 10.1136/heartjnl-2016-309852. Epub 2017 Jan 18.

PMID:
28100544
5.

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.

Mehta S, Sastry BK, Souza R, Torbicki A, Ghofrani HA, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O.

Chest. 2017 Jan;151(1):106-118. doi: 10.1016/j.chest.2016.08.1473. Epub 2016 Sep 23.

PMID:
27671974
6.

Utility of brief questionnaires of health-related quality of life (Airways Questionnaire 20 and Clinical COPD Questionnaire) to predict exacerbations in patients with asthma and COPD.

Blanco-Aparicio M, Vázquez I, Pita-Fernández S, Pértega-Diaz S, Verea-Hernando H.

Health Qual Life Outcomes. 2013 May 27;11:85. doi: 10.1186/1477-7525-11-85.

PMID:
23706146
7.

Emotional symptoms and quality of life in patients with pulmonary arterial hypertension.

M M Vanhoof J, Delcroix M, Vandevelde E, Denhaerynck K, Wuyts W, Belge C, Dobbels F.

J Heart Lung Transplant. 2014 Aug;33(8):800-8. doi: 10.1016/j.healun.2014.04.003. Epub 2014 Apr 19.

PMID:
24854567
8.

Exercise capacity affects quality of life in patients with pulmonary hypertension.

Halank M, Einsle F, Lehman S, Bremer H, Ewert R, Wilkens H, Meyer FJ, Grünig E, Seyfarth HJ, Kolditz M, Wieder G, Höffken G, Köllner V.

Lung. 2013 Aug;191(4):337-43. doi: 10.1007/s00408-013-9472-6. Epub 2013 May 17.

PMID:
23681593
9.

Lack of tight association between quality of life and exercise capacity in pulmonary arterial hypertension.

Cícero C, Franchi SM, Barreto AC, Lopes AA.

Arq Bras Cardiol. 2012 Oct;99(4):876-85. Epub 2012 Aug 30. English, Portuguese.

PMID:
22936028
10.

Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension.

Matura LA, McDonough A, Carroll DL.

J Pain Symptom Manage. 2016 Jan;51(1):25-32. doi: 10.1016/j.jpainsymman.2015.07.012. Epub 2015 Aug 20.

PMID:
26300023
11.

Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension.

Chaouat A, Sitbon O, Mercy M, Ponçot-Mongars R, Provencher S, Guillaumot A, Gomez E, Selton-Suty C, Malvestio P, Regent D, Paris C, Hervé P, Chabot F.

Eur Respir J. 2014 Sep;44(3):704-13. doi: 10.1183/09031936.00153613. Epub 2014 May 15.

PMID:
24833765
12.

Measurement of quality of life in pulmonary hypertension and its significance.

Cenedese E, Speich R, Dorschner L, Ulrich S, Maggiorini M, Jenni R, Fischler M.

Eur Respir J. 2006 Oct;28(4):808-15. Epub 2006 May 17.

PMID:
16707511
13.

Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosis.

Degano B, Sitbon O, Savale L, Garcia G, O'Callaghan DS, Jaïs X, Humbert M, Simonneau G.

Chest. 2010 Jun;137(6):1297-303. doi: 10.1378/chest.09-2060. Epub 2010 Jan 29.

PMID:
20118205
14.

Pulmonary arterial hypertension: the burden of disease and impact on quality of life.

Delcroix M, Howard L.

Eur Respir Rev. 2015 Dec;24(138):621-9. doi: 10.1183/16000617.0063-2015. Review.

PMID:
26621976
15.

Measuring disease-specific quality of life in obstructive airway disease: validation of a modified version of the airways questionnaire 20.

Chen H, Eisner MD, Katz PP, Yelin EH, Blanc PD.

Chest. 2006 Jun;129(6):1644-52.

PMID:
16778287
16.

The relationship of dyspnoea to function and quality of life in systemic sclerosis.

Baron M, Sutton E, Hudson M, Thombs B, Markland J, Pope J, Robinson D, Jones N, Docherty P, Abu-Hakima M, LeClercq S, Smith D, Mathieu JP.

Ann Rheum Dis. 2008 May;67(5):644-50. Epub 2007 Aug 29.

PMID:
17728334
17.

Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity.

Neal JE, Lee AS, Burger CD.

Clin Respir J. 2014 Oct;8(4):404-9. doi: 10.1111/crj.12085. Epub 2014 Jan 10.

PMID:
24308300
18.

Evaluation of 3 quality of life measurement tools in patients with chronic heart failure.

Sneed NV, Paul S, Michel Y, Vanbakel A, Hendrix G.

Heart Lung. 2001 Sep-Oct;30(5):332-40.

PMID:
11604975
19.

Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).

Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Strand V, Furst DE, Distler O; Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis.

J Rheumatol. 2011 Nov;38(11):2419-27. doi: 10.3899/jrheum.110344. Epub 2011 Oct 1. Review.

PMID:
21965635
20.

Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE study.

Amedro P, Basquin A, Gressin V, Clerson P, Jais X, Thambo JB, Guerin P, Cohen S, Bonnet D.

Cardiol Young. 2016 Oct;26(7):1250-9. doi: 10.1017/S1047951116000056. Epub 2016 Mar 16.

PMID:
26980152

Supplemental Content

Support Center